| [1] |
Blomström-Lundqvist C, Traykov V, Erba PA,et al. European Heart Rhythm Association(EHRA) international consensus document on how to prevent,diagnose,and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS),the Asia Pacific Heart Rhythm Society (APHRS),the Latin American Heart Rhythm Society (LAHRS),International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) [J]. Europace, 2020, 22(4):515-549. DOI: 10.1093/europace/euz246.
|
| [2] |
Essebag V, Verma A, Healey JS,et al. Clinically significant pocket hematoma increases long-term risk of device infection:BRUISE CONTROL INFECTION Study[J]. J Am Coll Cardiol, 2016, 67(11):1300-1308. DOI: 10.1016/j.jacc.2016.01.009.
|
| [3] |
Sticherling C, Marin F, Birnie D,et al. Antithrombotic management in patients undergoing electrophysiological procedures:a European Heart Rhythm Association (EHRA) position document endorsed by the ESC Working Group Thrombosis,Heart Rhythm Society (HRS),and Asia Pacific Heart Rhythm Society (APHRS)[J]. Europace, 2015, 17(8):1197-1214. DOI: 10.1093/europace/euv190.
|
| [4] |
Birnie DH, Healey JS, Wells GA,et al. Continued vs. interrupted direct oral anticoagulants at the time of device surgery,in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2) [J]. Eur Heart J, 2018, 39(44):3973-3979. DOI: 10.1093/eurheartj/ehy413.
|
| [5] |
Valgimigli M, Bueno H, Byrne RA,et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS:The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS)[J]. Eur Heart J, 2018, 39(3):213-260. DOI: 10.1093/eurheartj/ehx419.
|
| [6] |
Sandoe JA, Barlow G, Chambers JB,et al. Guidelines for the diagnosis,prevention and management of implantable cardiac electronic device infection. Report of a joint Working Party project on behalf of the British Society for Antimicrobial Chemotherapy (BSAC,host organization),British Heart Rhythm Society (BHRS),British Cardiovascular Society (BCS),British Heart Valve Society (BHVS) and British Society for Echocardiography (BSE)[J]. J Antimicrob Chemother, 2015, 70(2):325-359. DOI: 10.1093/jac/dku383.
|
| [7] |
Bischoff P, Kubilay NZ, Allegranzi B,et al. Effect of laminar airflow ventilation on surgical site infections:a systematic review and meta-analysis[J]. Lancet Infect Dis, 2017, 17(5):553-561. DOI: 10.1016/S1473-3099(17)30059-2.
|
| [8] |
de Oliveira JC, Martinelli M, Nishioka SA,et al. Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators:results of a large,prospective,randomized,double-blinded,placebo-controlled trial[J]. Circ Arrhythm Electrophysiol, 2009, 2(1):29-34. DOI: 10.1161/CIRCEP.108.795906.
|
| [9] |
|
| [10] |
余松峰, 刘争. 铺单(铺巾)[M]//姜保国,陈红. 中国医学生临床技能操作指南. 3版. 北京:人民卫生出版社,2020:99.
|
| [11] |
Tanawuttiwat T, Thisayakorn P, Viles-Gonzalez JF. LAST (local anesthetic systemic toxicity) but not least:systemic lidocaine toxicity during cardiac intervention[J]. J Invasive Cardiol, 2014, 26(1):E13-15.
|
| [12] |
Burri H, Starck C, Auricchio A,et al. EHRA expert consensus statement and practical guide on optimal implantation technique for conventional pacemakers and implantable cardioverter-defibrillators:endorsed by the Heart Rhythm Society (HRS),the Asia Pacific Heart Rhythm Society (APHRS),and the Latin-American Heart Rhythm Society (LAHRS)[J]. Europace, 2021, 23(7):983-1008. DOI: 10.1093/europace/euaa367.
|
| [13] |
Rajappan K. Permanent pacemaker implantation technique:part I:arrhythmias[J]. Heart, 2009, 95(3):259-264. DOI: 10.1136/hrt.2007.132753.
|
| [14] |
Oh JH, Kim CM, Song SY,et al. Transaxillary subpectoral placement of cardiac implantable electronic devices in young female patients[J]. Arch Plast Surg, 2017, 44(1):34-41. DOI: 10.5999/aps.2017.44.1.34.
|
| [15] |
Al-Bataineh M, Sajadi S, Fontaine JM,et al. Axillary subpectoral approach for pacemaker or defibrillator implantation in patients with ipsilateral prepectoral infection and limited venous access[J]. J Interv Card Electrophysiol, 2010, 27(2):137-142. DOI: 10.1007/s10840-009-9444-1.
|
| [16] |
Obeyesekere MN, Kamberi S, Youngs N,et al. Long-term performance of submammary defibrillator system[J]. Europace, 2010, 12(9):1239-1244. DOI: 10.1093/europace/euq152.
|
| [17] |
Roelke M, O′Nunain SS, Osswald S,et al. Subclavian crush syndrome complicating transvenous cardioverter defibrillator systems[J]. Pacing Clin Electrophysiol, 1995, 18(5 Pt 1):973-979. DOI: 10.1111/j.1540-8159.1995.tb04737.x.
|
| [18] |
|
| [19] |
|
| [20] |
Magney JE, Staplin DH, Flynn DM,et al. A new approach to percutaneous subclavian venipuncture to avoid lead fracture or central venous catheter occlusion[J]. Pacing Clin Electrophysiol, 1993, 16(11):2133-2142. DOI: 10.1111/j.1540-8159.1993.tb01018.x.
|
| [21] |
|
| [22] |
|
| [23] |
Hsu JC, Friday J, Lee BK,et al. Predictors of axillary vein location for vascular access during pacemaker and defibrillator lead implantation[J]. Pacing Clin Electrophysiol, 2011, 34(12):1585-1592. DOI: 10.1111/j.1540-8159.2011.03191.x.
|
| [24] |
Tagliari AP, Kochi AN, Mastella B,et al. Ultrasound-guided axillary vein puncture in cardiac lead implantation:time to move to a new standard access?[J]. Arrhythm Electrophysiol Rev, 2020, 9(2):78-82. DOI: 10.15420/aer.2020.17.
|
| [25] |
Mathur G, Stables RH, Heaven D,et al. Permanent pacemaker implantation via the femoral vein:an alternative in cases with contraindications to the pectoral approach[J]. Europace, 2001, 3(1):56-59. DOI: 10.1053/eupc.2000.0135.
|
| [26] |
Nesher N, Ganiel A, Paz Y,et al. Thoracoscopic epicardial lead implantation as an alternative to failed endovascular insertion for cardiac pacing and resynchronization therapy[J]. Innovations (Phila), 2014, 9(6):427-431. DOI: 10.1177/155698451400900606.
|
| [27] |
|
| [28] |
Hussain MA, Furuya-Kanamori L, Kaye G,et al. The effect of right ventricular apical and nonapical pacing on the short- and long-term changes in left ventricular ejection fraction:a systematic review and meta-analysis of randomized-controlled trials[J]. Pacing Clin Electrophysiol, 2015, 38(9):1121-1136. DOI: 10.1111/pace.12681.
|
| [29] |
Shimony A, Eisenberg MJ, Filion KB,et al. Beneficial effects of right ventricular non-apical vs. apical pacing:a systematic review and meta-analysis of randomized-controlled trials[J]. Europace, 2012, 14(1):81-91. DOI: 10.1093/europace/eur240.
|
| [30] |
Saito M, Iannaccone A, Kaye G,et al. Effect of right ventricular pacing on right ventricular mechanics and tricuspid regurgitation in patients with High-Grade Atrioventricular Block and Sinus Rhythm (from the Protection of Left Ventricular Function During Right Ventricular Pacing Study)[J]. Am J Cardiol, 2015, 116(12):1875-1882. DOI: 10.1016/j.amjcard.2015.09.041.
|
| [31] |
Schleifer JW, Pislaru SV, Lin G,et al. Effect of ventricular pacing lead position on tricuspid regurgitation:a randomized prospective trial[J]. Heart Rhythm, 2018, 15(7):1009-1016. DOI: 10.1016/j.hrthm.2018.02.026.
|
| [32] |
Burri H, Sunthorn H, Dorsaz PA,et al. Thresholds and complications with right ventricular septal pacing compared to apical pacing[J]. Pacing Clin Electrophysiol, 2007, 30 Suppl 1:S75-78. DOI: 10.1111/j.1540-8159.2007.00610.x.
|
| [33] |
Bongiorni MG, Proclemer A, Dobreanu D,et al. Preferred tools and techniques for implantation of cardiac electronic devices in Europe:results of the European Heart Rhythm Association survey[J]. Europace, 2013, 15(11):1664-1668. DOI: 10.1093/europace/eut345.
|
| [34] |
Rajappan K. Permanent pacemaker implantation technique:part Ⅱ[J]. Heart, 2009, 95(4):334-342. DOI: 10.1136/hrt.2008.156372.
|
| [35] |
Burri H, Domenichini G, Sunthorn H,et al. Comparison of tools and techniques for implanting pacemaker leads on the ventricular mid-septum[J]. Europace, 2012, 14(6):847-852. DOI: 10.1093/europace/eur404.
|
| [36] |
Squara F, Scarlatti D, Riccini P,et al. Individualized left anterior oblique projection:a highly reliable patient-tailored fluoroscopy criterion for right ventricular lead positioning[J]. Circ Arrhythm Electrophysiol, 2018, 11(7):e006107. DOI: 10.1161/CIRCEP.117.006107.
|
| [37] |
Osmancik P, Stros P, Herman D,et al. The insufficiency of left anterior oblique and the usefulness of right anterior oblique projection for correct localization of a computed tomography-verified right ventricular lead into the midseptum[J]. Circ Arrhythm Electrophysiol, 2013, 6(4):719-725. DOI: 10.1161/CIRCEP.113.000232.
|
| [38] |
Pang BJ, Joshi SB, Lui EH,et al. Validation of conventional fluoroscopic and ECG criteria for right ventricular pacemaker lead position using cardiac computed tomography[J]. Pacing Clin Electrophysiol, 2014, 37(4):495-504. DOI: 10.1111/pace.12301.
|
| [39] |
Mǎrgulescu AD, Suran BM, Rimbaş RC,et al. Accuracy of fluoroscopic and electrocardiographic criteria for pacemaker lead implantation by comparison with three-dimensional echocardiography[J]. J Am Soc Echocardiogr, 2012, 25(7):796-803. DOI: 10.1016/j.echo.2012.04.010.
|
| [40] |
Burri H, Park CI, Zimmermann M,et al. Utility of the surface electrocardiogram for confirming right ventricular septal pacing:validation using electroanatomical mapping[J]. Europace, 2011, 13(1):82-86. DOI: 10.1093/europace/euq332.
|
| [41] |
Schwaab B, Fröhlig G, Alexander C,et al. Influence of right ventricular stimulation site on left ventricular function in atrial synchronous ventricular pacing[J]. J Am Coll Cardiol, 1999, 33(2):317-323. DOI: 10.1016/s0735-1097(98)00562-2.
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
Fung JW, Sperzel J, Yu CM,et al. Multicenter clinical experience with an atrial lead designed to minimize far-field R-wave sensing[J]. Europace, 2009, 11(5):618-624. DOI: 10.1093/europace/eup078.
|
| [46] |
Witt CM, Lenz CJ, Shih HH,et al. Right atrial lead fixation type and lead position are associated with significant variation in complications[J]. J Interv Card Electrophysiol, 2016, 47(3):313-319. DOI: 10.1007/s10840-016-0181-y.
|
| [47] |
Zhang L, Jiang H, Wang W,et al. Interatrial septum versus right atrial appendage pacing for prevention of atrial fibrillation :a meta-analysis of randomized controlled trials[J]. Herz, 2018, 43(5):438-446. DOI: 10.1007/s00059-017-4589-7.
|
| [48] |
|
| [49] |
宿燕岗, 王蔚, 柏瑾,等. 低位房间隔起搏的临床应用[J]. 中国心脏起搏与心电生理杂志, 2009, 23(1):19-22.
|
| [50] |
Marshall HJ, Griffith MJ, Gammage MD. Placement of atrial pacing leads during atrial fibrillation. Feasibility and subsequent lead performance[J]. Europace, 1999, 1(2):131-134. DOI: 10.1053/eupc.1998.0030.
|
| [51] |
Rezazadeh S, Wang S, Rizkallah J. Evaluation of common suturing techniques to secure implantable cardiac electronic device leads:which strategy best reduces the lead dislodgement risk?[J]. Can J Surg, 2019, 62(1):E7-7. DOI: 10.1503/cjs.002418.
|
| [52] |
Darda S, Khouri Y, Gorges R,et al. Feasibility and safety of same-day discharge after implantable cardioverter defibrillator placement for primary prevention[J]. Pacing Clin Electrophysiol, 2013, 36(7):885-891. DOI: 10.1111/pace.12145.
|
| [53] |
Daniels JD, Sun S, Zafereo J,et al. Preventing shoulder pain after cardiac rhythm management device implantation:a randomized,controlled study[J]. Pacing Clin Electrophysiol, 2011, 34(6):672-678. DOI: 10.1111/j.1540-8159.2010.03026.x.
|
| [54] |
王辰, 申昆玲. 抗菌药物临床应用基本原则[M]//钟南山, 万希润, 马小军. 抗菌药物临床应用指导原则(2015年版). 北京:人民卫生出版社,2015:5-9.
|
| [55] |
Deuling JH, Smit MD, Maass AH,et al. The value and limitations of a wound inspection clinic after cardiac device implantation[J]. Eur J Cardiovasc Nurs, 2009, 8(4):288-292. DOI: 10.1016/j.ejcnurse.2009.02.007.
|
| [56] |
Discalzi A, Maglia C, Ciferri F,et al. Percutaneous closure of accidentally subclavian artery catheterization:time to change first line approach?[J]. CVIR Endovasc, 2022, 5(1):23. DOI: 10.1186/s42155-022-00300-7.
|
| [57] |
Meyhoefer J, Lehmann H, Minden HH,et al. Closure of the subclavian artery puncture site with a percutaneous suture device after removal of an arterial pacemaker lead[J]. Europace, 2006, 8(12):1070-1072. DOI: 10.1093/europace/eul129.
|
| [58] |
Bartorelli AL, Trabattoni D, Agrifoglio M,et al. Endovascular repair of latrogenic subclavian artery perforations using the Hemobahn stent-graft[J]. J Endovasc Ther, 2001, 8(4):417-421. DOI: 10.1177/152660280100800411.
|
| [59] |
Chen X, Bai J, Han F,et al. Percutaneous closure of the inadvertent subclavian artery cannulation during pacemaker implantation[J]. Cardiol J, 2017, 24(4):452-454. DOI: 10.5603/CJ.2017.0093.
|
| [60] |
Molnár L, Szucs G, Zima E,et al. Successful management and long term outcome of an accidental subclavian artery injury with a 9 french dilator during pacemaker implantation with collagen-based closure device[J]. J Interv Card Electrophysiol, 2009, 25(3):217-218. DOI: 10.1007/s10840-008-9362-7.
|
| [61] |
Alvarez-Acosta L, Romero Garrido R, Farrais-Villalba M,et al. Reel syndrome:a rare cause of pacemaker malfunction[J]. BMJ Case Rep, 2014:bcr2014204545. DOI: 10.1136/bcr-2014-204545.
|
| [62] |
Von Bergen NH, Atkins DL, Gingerich JC,et al. "Ratchet" syndrome,another etiology for pacemaker lead dislodgement:a case report[J]. Heart Rhythm, 2007, 4(6):788-789. DOI: 10.1016/j.hrthm.2006.12.029.
|
| [63] |
Vijay SK, Dwivedi SK, Chandra S,et al. Ratchet-traction effect:an underdiagnosed mechanism of pacing lead dislodgement[J]. Indian Heart J, 2014, 66(5):555-556. DOI: 10.1016/j.ihj.2014.05.005.
|
| [64] |
Klug D, Balde M, Pavin D,et al. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators:results of a large prospective study[J]. Circulation, 2007, 116(12):1349-1355. DOI: 10.1161/CIRCULATIONAHA.106.678664.
|
| [65] |
|
| [66] |
Kusumoto FM, Schoenfeld MH, Wilkoff BL,et al. 2017 HRS Expert consensus statement on cardiovascular implantable electronic device lead management and extraction[J]. Heart Rhythm, 2017, 14(12):e503-e551. DOI: 10.1016/j.hrthm.2017.09.001.
|
| [67] |
Krahn AD, Longtin Y, Philippon F,et al. Prevention of arrhythmia device infection trial:the PADIT trial[J]. J Am Coll Cardiol, 2018, 72(24):3098-3109. DOI: 10.1016/j.jacc.2018.09.068.
|
| [68] |
|
| [69] |
Varma N, Schaerf R, Kalbfleisch S,et al. Defibrillation thresholds with right pectoral implantable cardioverter defibrillators and impact of waveform tuning (the Tilt and Tune trial) [J]. Europace, 2017, 19(11):1810-1817. DOI: 10.1093/europace/euw306.
|
| [70] |
Gold MR, Shih HT, Herre J,et al. Comparison of defibrillation efficacy and survival associated with right versus left pectoral placement for implantable defibrillators[J]. Am J Cardiol, 2007, 100(2):243-246. DOI: 10.1016/j.amjcard.2007.02.087.
|
| [71] |
Reynolds CR, Nikolski V, Sturdivant JL,et al. Randomized comparison of defibrillation thresholds from the right ventricular apex and outflow tract[J]. Heart Rhythm, 2010, 7(11):1561-1566. DOI: 10.1016/j.hrthm.2010.06.017.
|
| [72] |
Mollerus M, Lipinski M, Munger T. A randomized comparison of defibrillation thresholds in the right ventricular outflow tract versus right ventricular apex[J]. J Interv Card Electrophysiol, 2008, 22(3):221-225. DOI: 10.1007/s10840-008-9254-x.
|
| [73] |
Crossley GH, Boyce K, Roelke M,et al. A prospective randomized trial of defibrillation thresholds from the right ventricular outflow tract and the right ventricular apex[J]. Pacing Clin Electrophysiol, 2009, 32(2):166-171. DOI: 10.1111/j.1540-8159.2008.02198.x.
|
| [74] |
Kolb C, Solzbach U, Biermann J,et al. Safety of mid-septal electrode placement in implantable cardioverter defibrillator recipients--results of the SPICE (Septal Positioning of ventricular ICD Electrodes) study[J]. Int J Cardiol, 2014, 174(3):713-720. DOI: 10.1016/j.ijcard.2014.04.229.
|
| [75] |
Mabo P, Defaye P, Mouton E,et al. A randomized study of defibrillator lead implantations in the right ventricular mid-septum versus the apex:the SEPTAL study[J]. J Cardiovasc Electrophysiol, 2012, 23(8):853-860. DOI: 10.1111/j.1540-8167.2012.02311.x.
|
| [76] |
Healey JS, Hohnloser SH, Glikson M,et al. Cardioverter defibrillator implantation without induction of ventricular fibrillation:a single-blind,non-inferiority,randomised controlled trial (SIMPLE) [J]. Lancet, 2015, 385(9970):785-791. DOI: 10.1016/S0140-6736(14)61903-6.
|
| [77] |
Uslan DZ, Gleva MJ, Warren DK,et al. Cardiovascular implantable electronic device replacement infections and prevention:results from the REPLACE Registry[J]. Pacing Clin Electrophysiol, 2012, 35(1):81-87. DOI: 10.1111/j.1540-8159.2011.03257.x.
|
| [78] |
Goldenberg GR, Barsheshet A, Bishara J,et al. Effect of fibrotic capsule debridement during generator replacement on cardiac implantable electronic device infection risk[J]. J Interv Card Electrophysiol, 2020, 58(1):113-118. DOI: 10.1007/s10840-019-00581-4.
|